From Reddit posted by texinsd45:
Motion Hearing 4-15
From Reddit posted by texinsd45:
Motion Hearing 4-15 10am.
I left the hearing around noon. I am hearing on other chats that BDFR was there as well. He sat in front row behind prosecutors for those that dont believe me. He was wearing shorts and left early. I did not have a pencil to take notes, and I am not MGK but here’s the cliff note version.
1) The files are going to be sealed, only because of the email addresses that they contain, and those persons receiving negative emails from investors. They will be un sealed once the email addresses are redacted. Moving forward all email addresses will be taken off documents prior to becoming public. All new emails will not contain email addresses, but it was acknowledged that these email addresses will become public at the trial.
2) Kazam was present, Nader was not.
3) The trial may be delayed because of findings in the new FDA communications with so much negativity towards Cytodyn. The defense has identified three more persons that they need to see their emails. As they had a negative opinion of Cytodyn prior to the BLA being filed.
4) Kazems Defense stated that they did file an incomplete BLA, but should’ve been given a chance to send in the missing data points. I guess this is not uncommon. They were expecting to have the FDA come back with some guidance and allow them to submit the missing data points in a couple days after submitting. But his defense states that FDA was not going to give it a chance.
6) Early arguments from Govt that some of Kaz and Naders “expert witnesses may not be experts. Judge seemed to disagree.
7) The judge did rule against the prosecution and they must get with FDA to get the three person emails in a certain time frame. The prosecution said they will try to have the emails to the defense team by Thursday, both parties will talk to the judge on Monday to see if the trial needs to be delayed.
Again, I am not MGK, and I am writing this going down the road with voice dictation. Apologize for any errors.
21
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...
Continue Reading
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...
Continue Reading
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...
Continue Reading
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...
Continue Reading
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
Top 5 Most Recently Viewed Articles
Dividend Announcement by Safe and Green Development Corporation Safe and Green Development Corporation (NASDAQ: SGD) has recently shared important updates regarding its stock dividend. These updates include confirmation of the trading date on a stock dividend-adjusted basis and details of the dividend share distribution. Details of the Stock Dividend On an earlier date,...
Continue Reading
Understanding Your Rights as a Revance Therapeutics Investor Investing in pharmaceuticals can be both rewarding and risky. If you're an investor in Revance Therapeutics, Inc., it's crucial to stay informed about your rights and the recent allegations surrounding the company. The current situation offers you the opportunity to seek compensation for any potential losses...
Continue Reading
Curbio CEO Rick Rudman Honored by HousingWire Curbio, a leading home improvement company that serves real estate agents, is excited to share that its CEO, Rick Rudman, has been named a recipient of the prestigious 2024 HousingWire Vanguards Award. This award celebrates outstanding leaders who have made a significant impact on their organizations, especially in navigating...
Continue Reading
CoinShares and Vine Hill Capital: A Strategic Merger CoinShares International Limited, a prominent asset manager focused on digital assets, has revealed its plans for a significant corporate transition. In collaboration with Vine Hill Capital Investment Corp., a listed special purpose acquisition company on the Nasdaq Stock Market, CoinShares is set to undergo a strategic...
Continue Reading
Intel Corporation's Current Market Standing Roth/MKM has reaffirmed a neutral outlook on Intel Corporation (NASDAQ: INTC), keeping the price target for its shares at $25.00. This decision comes after Intel's recent announcements about improvements in its foundry manufacturing capabilities and its strategic approach to managing its overall portfolio. Strategic Focus and...
Continue Reading